Home Research funding Healthtech start-up NIRAMAI receives research funding from CDC group for a...

[Funding alert] Healthtech start-up NIRAMAI receives research funding from CDC group for a COVID screening solution


Startup Deeptech in the health sector seNiramaïseHealth Analytix on Tuesday raised research funding from the UK-based development finance institution and impact investor CDC for NIRAMAI FeverTest, which launched last year.

NIRAMAI FeverTest is smart software that can screen for symptoms of COVID-19 in public places by leveraging computer vision and AI to analyze and monitor crowd compliance with COVID-19 guidelines.

The Bengaluru-based startup’s COVID-19 screening technology helps screen for symptoms such as fever and respiratory illnesses at entrances to workplaces, hospitals, educational institutions, residential communities and public places.

Srini Nagarajan, Managing Director, South Asia at CDC Group, said:

“Tracking and controlling the rapid spread of the virus in the community remains a major challenge. NIRAMAI FeverTest is a technology that will amplify efforts to save lives, preserve public safety and reduce the economic impact of the pandemic in India. Its innovative solutions will complement the national response to the fight against COVID-19 and we are delighted that the technology can help India meet the challenge head-on, bolstering the country’s measures to bring the pandemic under control. ”

The technology is being deployed at two major stations in Bangalore in partnership with South Western Railways, which is helping Railway Protection Force personnel transparently scan thousands of commuters to comply with COVID-19 protection measures.

“The financial support from CDC has enabled us to successfully pilot our AI-activated COVID screening product in IT technology parks, schools and some hospitals in Indian cities,” said Geetha Manjunath, Founder and CEO of NIRAMAI in a statement.

Supported by Pi Ventures, NIRAMAI is a pioneer in the development of breast cancer screening solutions based on AI and thermal imaging. The startup’s cloud-hosted analytics solution uses big data analytics, artificial intelligence and machine learning algorithms for early detection of breast cancer.

In June 2020, NIRAMAI launched a home breast cancer screening service, ensuring that a technician will assist it within 48 hours of making an appointment.